DOCSLIB.ORG

Annual Review

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Review ANNUAL REVIEW 2005 THE WELLCOME TRUST The Wellcome Trust is the most diverse biomedical research charity in the world, supporting a spectrum of activity from basic science to history of medicine. CONTENTS BOARD OF GOVERNORS 2 Director’s statement Dominic Cadbury Chairman 4 Advancing knowledge Martin Bobrow 16 Using knowledge Deputy Chairman 22 Engaging society Leszek Borysiewicz* 28 Developing people Adrian Bird 32 Facilitating research William Castell* 36 Developing our organisation Patricia Hodgson Ronald Plasterk 37 Wellcome Trust 2004/05 Alastair Ross Goobey 38 Funding 2004/05 Peter Smith 52 Advisory committees Jean Thomas Edward Walker-Arnott *From 1 January 2006 L–R Human cells in culture. ‘Ball and stick’ molecular Signage within the modelling. Wellcome Trust’s new ‘Germlights’ by Sue headquarters building Withers, Proof, from a at 215 Euston Road, Wellcome Trust science London. and art exhibition. Professor Andy Tait of Professor Andrew the Wellcome Trust Hattersley of the This Annual Review covers the Wellcome Centre for Molecular University of Exeter Parasitology in Glasgow. examining a patient Trust’s financial year, from 1 October with diabetes. 2004 to 30 September 2005. CONTENTS 01 EXECUTIVE BOARD MAKING A DIFFERENCE Developing people: To foster a Mark Walport The Wellcome Trust’s mission is research community and individual Director of the Wellcome Trust to foster and promote research with researchers who can contribute to the advancement and use of knowledge Ted Bianco the aim of improving human and Director of Technology Transfer animal health. During 2005–2010, Facilitating research: To promote the our aims are: best conditions for research and the John Cooper use of knowledge Director of Resources Advancing knowledge: To support research to increase understanding Developing our organisation: To use David Lynn of health and disease, and its our resources efficiently and effectively. Head of Strategic Planning and Policy societal context Clare Matterson Using knowledge: To support the Director of Medicine, Society development and use of knowledge and History to create health benefit David Phillipps Engaging society: To engage with Director of Finance society to foster an informed climate Sohaila Rastan within which biomedical research Director of Science Funding can flourish John Stewart Head of Legal and Company Secretary Danny Truell Chief Investment Officer As at January 2006 DIRECTOR’S STATEMENT 02 A YEAR OF DISCOVERY It has been a year that demonstrates that investing in the best people to work on the best ideas in the best environments produces landmark discoveries. One of the greatest satisfactions Last year Dr Georgy Koentges and 1991–92 and their parents, which we of directing the Wellcome Trust colleagues made ground-breaking fund jointly with the Medical Research is seeing the many discoveries steps forward in the understanding of Council, continue to produce emerging from the research we how our skeletons and muscles develop, important findings. fund. The most effective way to and why certain genetic disorders affect Research resources fund the research that leads to particular parts of our bodies. This has The year also saw the fruit of several new discoveries is to support the significantly altered our view of a key large international collaborative projects, best researchers, the best teams biological process, as has the work of in which the Trust is a major partner. and the best ideas. To help guide Professor Adrian Hayday and colleagues These build on the Human Genome our research communities and at King’s College London. They have Project, aiming to translate genome provide them with the opportunities discovered that immature T cells have sequence data to give a better to make real progress, this year a crucial role in generating special understanding of health and disease. we launched our Strategic Plan defence cells that patrol the vulnerable 2005–2010: Making a Difference. sites exposed to the outside world, such The International HapMap Consortium as skin and the gut. This has created a published a detailed catalogue of The new Plan is about creating a new view of the thymus function. human genetic variation, which is framework (see page 36), a set of already accelerating the search for high-level principles to guide – but not In the clinical arena, this year saw genes involved in common diseases. constrain – research communities that the results of the largest-ever clinical trial The Wellcome Trust Sanger Institute look to us for funding. The Strategic Plan on the treatment of severe malaria. This played a key role in generating this map. will be a living document, allowing us to work in South-east Asia, led by Professor In another outstanding year, the Sanger adjust our direction as new opportunities Nick White, brought calls for immediate Institute took a key role in international arise. Key to this will be flexibility in our change to medication practices. partnerships that sequenced the mechanisms for awarding grants. This In Vietnam, Dr Jeremy Farrar and genomes of parasites causing three year we launched a Strategic Awards colleagues have advanced our major diseases in developing countries – scheme, with grants that will enable us understanding of avian influenza in sleeping sickness, Chagas’ disease to fund strategic initiatives of many kinds humans. Their research suggests that and leishmaniasis – and the human in a timely manner. We also broadened the virus can affect many parts of the X chromosome. our UK eligibility criteria, so that we can body – not just the lungs, as previously Knowing the shape of a protein is fund the best scientists throughout the thought. The core funding of the Vietnam crucial for understanding its biological UK and enable them to collaborate with Programme and our other Major function, and the Structural Genomics scientists worldwide. Overseas Programmes in Kenya and Consortium (SGC), a public–private Thailand was renewed this year. Funding Discoveries partnership between the Wellcome Trust, of £26 million was agreed in recognition Support of curiosity-driven research GlaxoSmithKline, and funding agencies of the internationally important work remains the biggest single element of our in Canada and Sweden, is determining these Programmes are carrying out. funding portfolio. Such support has led the three-dimensional structures of to some outstanding research outputs – In the UK, researchers working with proteins relevant to human disease. discoveries that give us a better ALSPAC, a cohort study of 14 000 The SGC has, to date, solved the understanding of health and disease. children born in the Avon area in structures of over 100 complex proteins, DIRECTOR’S STATEMENT 03 HIGHLIGHTS OF THE YEAR including important drug development A supportive environment • Artesunate is more effective than targets for malaria and diabetes. To achieve our mission, we need quinine for treatment of severe These are tremendous research a climate within which biomedical malaria, a large clinical trial in resources, all freely available to research can flourish. The Trust Asia reveals. has again been active in this area. researchers around the globe. • Genome sequences of Last year we also agreed to fund The completion of the National Science two important parasites, another such community resource. Learning Centre is an important step Trypanosoma brucei and The Wellcome Trust Case Control forward. It will provide teachers and Leishmania, are published. Consortium will be one of the biggest other educators with access to the • Building work is completed on projects ever undertaken to identify resources and expertise to get to grips the National Science Learning the genetic variations that may with the complexities of contemporary Centre at York. predispose people to, or protect science. In turn, teachers will go on them from, 11 major diseases, to inspire today’s young people to • Community MRSA is identified including type 1 diabetes, Crohn’s become the scientists of tomorrow, as a re-emergent strain from disease and rheumatoid arthritis. and give them the confidence to the 1950s. Practical application understand, debate and question • Work on early T-cell development Key to our mission is ensuring that issues surrounding science. sheds new light on the thymus. research knowledge results in health This year we have again been actively • Structural Genomics Consortium benefit. CardioDigital Limited, a spin- engaging with Government, policy places structures of 100 out company from Napier University, makers and opinion formers on issues medically important proteins Edinburgh, has developed and is affecting the research base. These in the public domain. piloting software that can significantly include stem cell research, use of enhance the information extracted human tissues, career structures for • Source of calories, not just from existing medical hardware, clinical and basic scientists, and number, influences lifespan in such as pulse oximeters. continuing professional development fruit flies fed low-calorie diets. for science teachers. We have also Professor Steve Howdle, Professor • Bacterial illness is found to actively promoted the ‘open access’ Vladimir Popov and colleagues have account for an unexpectedly high model of science publishing, to help developed ‘PolyHap’ implants, which proportion of deaths of African ensure that research findings are have been used by surgeons to help children admitted to hospital. shared as widely and as rapidly rebuild the faces
Load more

Recommended publications
  • The Business Bug Master’S Message College News
    Optima Fitzwilliam College Newsletter | Issue 17 | Spring 2011 The Catalan Connection | Solar Paint | Medics and Vets Reunion | The Business Bug Master’s message College News No reader of Optima can fail to be aware of the challenges now facing us. The government’s cutting of the teaching budget by 80% has Duke of Edinburgh opens implications even for Cambridge. A tuition fee of £9,000 will cover Library & IT Centre barely half the cost of educating a student here. His Royal Highness the Duke of Edinburgh KG KT, Chancellor of the University and Visitor of But this issue of Optima again the College, made his fifth visit to Fitzwilliam reminds us why we must sustain on 19 April 2010 to open the Library & IT our commitment to a collegiate Centre in the presence of benefactors, experience which is both Fellows, students and staff. The building intellectual and enriching in a wider Architects’ sense. It contains news items of featured on the cover of the importance, such as the completion Journal in March. of the modern Fitzwilliam in the shape of the formal opening of the This exciting new building, designed by new Library and IT Centre, while Edward Cullinan Architects, has recalling another historic moment – transformed the College’s academic our 1979 move to coeducation. provision and is popular with students. It refers to great public academic The Library features in the short film occasions such as the Foundation ‘The Perfect Desk’ commissioned by the Lecture. It underlines the University to show the role of college JET photographic JET international dimension of the libraries in the academic life of students.
    [Show full text]
  • ANNUAL REVIEW 1 October 2005–30 September
    WELLCOME TRUST ANNUAL REVIEW 1 October 2005–30 September 2006 ANNUAL REVIEW 2006 The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. www.wellcome.ac.uk THE WELLCOME TRUST The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. 123 CONTENTS BOARD OF GOVERNORS 2 Director’s statement William Castell 4 Advancing knowledge Chairman 16 Using knowledge Martin Bobrow Deputy Chairman 24 Engaging society Adrian Bird 30 Developing people Leszek Borysiewicz 36 Facilitating research Patricia Hodgson 40 Developing our organisation Richard Hynes 41 Wellcome Trust 2005/06 Ronald Plasterk 42 Financial summary 2005/06 Alastair Ross Goobey 44 Funding developments 2005/06 Peter Smith 46 Streams funding 2005/06 Jean Thomas 48 Technology Transfer Edward Walker-Arnott 49 Wellcome Trust Genome Campus As at January 2007 50 Public Engagement 51 Library and information resources 52 Advisory committees Images 1 Surface of the gut. 3 Zebrafish. 5 Cells in a developing This Annual Review covers the 2 Young children in 4 A scene from Y fruit fly. Wellcome Trust’s financial year, from Kenya. Touring’s Every Breath. 6 Data management at the Sanger Institute. 1 October 2005 to 30 September 2006. CONTENTS 1 45 6 EXECUTIVE BOARD MAKING A DIFFERENCE Developing people: To foster a Mark Walport The Wellcome Trust’s mission is research community and individual Director to foster and promote research with researchers who can contribute to the advancement and use of knowledge Ted Bianco the aim of improving human and Director of Technology Transfer animal health.
    [Show full text]
  • President's Message
    Winter Issue 2013–2014 SOT News President’s Message I’m starting this President’s message with a quiz!!! It’s just one question, but it’s important that everyone knows the answer. The question is: What do prenatal programming and toxicity, perfluorinalkyl acids ,and human relevance of hemangiosarcomas in rodents have in common? [the answer appears at the end of this message]. While you ponder the answer to that question, I want to reflect on events of this fall and focus on several activities of the Society during recent times of uncertainty. The shutdown of the US government had some effect on nearly all of us. Important meetings, study sections, and day-to- day professional discussion and dialog were all furloughed during this time. However, the most significant impact was on our members who are government employees, and we can only hope that these matters are completely behind us. Unfortunately, there were significant deadlines for SOT matters scheduled during this time, particularly for abstract submissions and award President nominations. Lois D. Lehman- McKeeman I want to specifically acknowledge the work of the Scientific Program and Awards Committees for showing remarkable flexibility in modifying deadlines to accommodate member needs. As a quick review, the Awards committee moved deadlines for nominations to the last possible minute—giving them only about 1 week to review all nominations prior to meeting to select award winners. The prestigious Society awards are central to celebrating member accomplishments, and the work of this committee, against their own time limitations, underscores their commitment to this important activity.
    [Show full text]
  • Jeremy Farrar
    FEATURE The BMJ THE BMJ INTERVIEW BMJ: first published as 10.1136/bmj.n459 on 19 February 2021. Downloaded from [email protected] Cite this as: BMJ 2021;372:n459 http://dx.doi.org/10.1136/bmj.n459 Jeremy Farrar: Make vaccine available to other countries as soon as Published: 19 February 2021 our most vulnerable people have received it The SAGE adviser and Wellcome Trust director tells Mun-Keat Looi how the UK government acted too slowly against the pandemic, about the perils of vaccine nationalism, and why he is bullish about controlling covid variants Mun-Keat Looi international features editor “Once the UK has vaccinated our most vulnerable among healthcare workers. We had no human communities and healthcare workers we should make immunity, no diagnostics, no treatment, and no vaccines available to other countries,” insists the vaccines. infectious disease expert Jeremy Farrar. This could Every country should have acted then. Singapore, avert further public health and economic disaster, China, and South Korea did. Yet most of Europe and he says, describing it as “enlightened self-interest, North America waited until the middle of March, and as well as the right ethical thing to do.” that defined the first wave. Countries including the In April 2020, soon after the first UK lockdown began, UK were unwilling to act early, before they felt Farrar predicted that the UK would have one of the comfortable; were unwilling to go deeper than they worst covid-19 death rates in Europe. As a member thought they had to; and were unwilling to keep of the Scientific Advisory Group for Emergencies restrictions in place for as long as was needed.
    [Show full text]
  • Society for Developmental Biology 64Th Annual Meeting
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Biology 283 (2005) 537 – 574 www.elsevier.com/locate/ydbio Society for Developmental Biology 64th Annual Meeting Hyatt Regency, San Francisco, CA July 27–August 1, 2005 Organizing Committee: Judith Kimble (Chair, SDB President), Kathy Barton, Minx Fuller, Nipam Patel, Didier Stainier, Xin Sun, Bill Wood Local Organizers: Didier Stainier, Ida Chow Numbers in italics are program abstract numbers and names in bold are speakers. Poster assignments are listed at the end of the meeting program. Program Wednesday, July 27 9 am–5 pm Satellite Symposia (not organized by SDB) Segmentation Seacliff AB Co-organizers: Kenro Kusumi and Olivier Pourquie´ Molecular Biology of Plant Development Seacliff CD Organizer: Kathy Barton 12–7 pm Meeting Registration Grand Foyer Poster Session I and Exhibits Set-up Pacific Concourse See poster assignments at the end of the program 7–9 pm President’s Symposium Grand Ballroom Fundamental Problems of Developmental Biology Chair: Judith Kimble, University of Wisconsin-Madison and HHMI, Madison, WI 7:00 The soma-germline dichotomy. G. Seydoux. Johns Hopkins University, Baltimore, MD 1 7:40 MicroRNAs and their regulatory roles in plants and animals. D.P. Bartel. MIT and Whitehead Institute for Biomedical Research, Cambridge, MA 8:20 The genetics and genomics of evolving new traits in vertebrates. D. Kingsley. Stanford University and HHMI, Stanford, CA 9–11 pm Opening Reception in Honor of Eric Olson, Pacific Concourse Developmental Biology Editor-in-Chief, for invaluable service to the community Poster Session I and Exhibits Pacific Concourse See poster assignments at the end of the program YDBIO-02007; No.
    [Show full text]
  • Download Our Exhibition Catalogue
    CONTENTS Published to accompany the exhibition at Foreword 04 Two Temple Place, London Dodo, by Gillian Clarke 06 31st january – 27th april 2014 Exhibition curated by Nicholas Thomas Discoveries: Art, Science & Exploration, by Nicholas Thomas 08 and Martin Caiger-Smith, with Lydia Hamlett Published in 2014 by Two Temple Place Kettle’s Yard: 2 Temple Place, Art and Life 18 London wc2r 3bd Museum of Archaeology and Anthropology: Copyright © Two Temple Place Encountering Objects, Encountering People 24 A catalogue record for this publication Museum of Classical Archaeology: is available from the British Library Physical Copies, Metaphysical Discoveries 30 isbn 978-0-9570628-3-2 Museum of Zoology: Designed and produced by NA Creative Discovering Diversity 36 www.na-creative.co.uk The Sedgwick Museum of Earth Sciences: Cover Image: Detail of System According to the Holy Scriptures, Muggletonian print, Discovering the Earth 52 plate 7. Drawn by Isaac Frost. Printed in oil colours by George Baxter Engraved by Clubb & Son. Whipple Museum of the History of Science, The Fitzwilliam Museum: University of Cambridge. A Remarkable Repository 58 Inside Front/Back Cover: Detail of Kitagawa Utamaro (1753-1806), Komei bijin mitate The Polar Museum: Choshingura junimai tsuzuki (The Choshingura drama Exploration into Science 64 parodied by famous beauties: A set of twelve prints). The Fitzwilliam Museum, University of Cambridge. Whipple Museum of the History of Science: Thinking about Discoveries 70 Object List 78 Two Temple Place 84 Acknowledgements 86 Cambridge Museums Map 87 FOREWORD Over eight centuries, the University of Cambridge has been a which were vital to the formation of modern understandings powerhouse of learning, invention, exploration and discovery of nature and natural history.
    [Show full text]
  • Gurdon Institute 20122011 PROSPECTUS / ANNUAL REPORT 20112010
    The Wellcome Trust/Cancer Research UK Gurdon Institute 20122011 PROSPECTUS / ANNUAL REPORT 20112010 Gurdon I N S T I T U T E PROSPECTUS 2012 ANNUAL REPORT 2011 http://www.gurdon.cam.ac.uk CONTENTS THE INSTITUTE IN 2011 INTRODUCTION........................................................................................................................................3 HISTORICAL BACKGROUND..........................................................................................................4 CENTRAL SUPPORT SERVICES....................................................................................................5 FUNDING.........................................................................................................................................................5 RETREAT............................................................................................................................................................5 RESEARCH GROUPS.........................................................................................................6 MEMBERS OF THE INSTITUTE................................................................................44 CATEGORIES OF APPOINTMENT..............................................................................44 POSTGRADUATE OPPORTUNITIES..........................................................................44 SENIOR GROUP LEADERS.............................................................................................44 GROUP LEADERS.......................................................................................................................48
    [Show full text]
  • EMBC Annual Report 2007
    EMBO | EMBC annual report 2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Hermann Bujard, EMBO 4 preface by Tim Hunt and Christiane Nüsslein-Volhard, EMBO Council 6 preface by Marja Makarow and Isabella Beretta, EMBC 7 past & present timeline 10 brief history 11 EMBO | EMBC | EMBL aims 12 EMBO actions 2007 15 EMBC actions 2007 17 EMBO & EMBC programmes and activities fellowship programme 20 courses & workshops programme 21 young investigator programme 22 installation grants 23 science & society programme 24 electronic information programme 25 EMBO activities The EMBO Journal 28 EMBO reports 29 Molecular Systems Biology 30 journal subject categories 31 national science reviews 32 women in science 33 gold medal 34 award for communication in the life sciences 35 plenary lectures 36 communications 37 European Life Sciences Forum (ELSF) 38 ➔ 2 table of contents appendix EMBC delegates and advisers 42 EMBC scale of contributions 49 EMBO council members 2007 50 EMBO committee members & auditors 2007 51 EMBO council members 2008 52 EMBO committee members & auditors 2008 53 EMBO members elected in 2007 54 advisory editorial boards & senior editors 2007 64 long-term fellowship awards 2007 66 long-term fellowships: statistics 82 long-term fellowships 2007: geographical distribution 84 short-term fellowship awards 2007 86 short-term fellowships: statistics 104 short-term fellowships 2007: geographical distribution 106 young investigators 2007 108 installation
    [Show full text]
  • Science & Policy Meeting Jennifer Lippincott-Schwartz Science in The
    SUMMER 2014 ISSUE 27 encounters page 9 Science in the desert EMBO | EMBL Anniversary Science & Policy Meeting pageS 2 – 3 ANNIVERSARY TH page 8 Interview Jennifer E M B O 50 Lippincott-Schwartz H ©NI Membership expansion EMBO News New funding for senior postdoctoral In perspective Georgina Ferry’s enlarges its membership into evolution, researchers. EMBO Advanced Fellowships book tells the story of the growth and ecology and neurosciences on the offer an additional two years of financial expansion of EMBO since 1964. occasion of its 50th anniversary. support to former and current EMBO Fellows. PAGES 4 – 6 PAGE 11 PAGES 16 www.embo.org HIGHLIGHTS FROM THE EMBO|EMBL ANNIVERSARY SCIENCE AND POLICY MEETING transmissible cancer: the Tasmanian devil facial Science meets policy and politics tumour disease and the canine transmissible venereal tumour. After a ceremony to unveil the 2014 marks the 50th anniversary of EMBO, the 45th anniversary of the ScienceTree (see box), an oak tree planted in soil European Molecular Biology Conference (EMBC), the organization of obtained from countries throughout the European member states who fund EMBO, and the 40th anniversary of the European Union to symbolize the importance of European integration, representatives from the govern- Molecular Biology Laboratory (EMBL). EMBO, EMBC, and EMBL recently ments of France, Luxembourg, Malta, Spain combined their efforts to put together a joint event at the EMBL Advanced and Switzerland took part in a panel discussion Training Centre in Heidelberg, Germany, on 2 and 3 July 2014. The moderated by Marja Makarow, Vice President for Research of the Academy of Finland.
    [Show full text]
  • Financing Vaccines for Global Health Security
    NBER WORKING PAPER SERIES FINANCING VACCINES FOR GLOBAL HEALTH SECURITY Jonathan T. Vu Benjamin K. Kaplan Shomesh Chaudhuri Monique K. Mansoura Andrew W. Lo Working Paper 27212 http://www.nber.org/papers/w27212 NATIONAL BUREAU OF ECONOMIC RESEARCH 1050 Massachusetts Avenue Cambridge, MA 02138 May 2020 We thank Ellen Carlin, Doug Criscitello, Margaret Crotty, Narges Dorratoltaj, Per Etholm, Jeremy Farrar, Nimah Farzan, Mark Feinberg, Jose-Maria Fernandez, John Grabenstein, Peter Hale, Richard Hatchett, Peter Hotez, Daniel Kaniewski, Adel Mahmoud, Mike Osterholm, May 2020 Farrar, Nimah Kevin Outterson, Chi Heem Wong, CEPI leadership, and two reviewers and the editor for helpful comments and discussion, and Jayna Cummings for editorial assistance. Research support from the MIT Laboratory for Financial Engineering and the Warren Alpert Medical School of Brown University is gratefully acknowledged. The views and opinions expressed in this article are those of the authors only, and do not necessarily represent the views and opinions of any institution or agency, any of their affiliates or employees, any of the individuals acknowledged above, or the National Bureau of Economic Research. Funding support from the MIT Laboratory for Financial Engineering is gratefully acknowledged, but no direct funding was received for this study and no funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. The authors were personally salaried by their institutions during the period of writing (though no specific salary was set aside or given for the writing of this manuscript). At least one co-author has disclosed a financial relationship of potential relevance for this research.
    [Show full text]
  • Jarid2 Coordinates Nanog Expression and PCP/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Developmen
    Article Jarid2 Coordinates Nanog Expression and PCP/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Development Graphical Abstract Authors David Landeira, Hakan Bagci, Andrzej R. Malinowski, ..., Thomas Carroll, Matthias Merkenschlager, Amanda G. Fisher Correspondence [email protected] (D.L.), amanda.fi[email protected] (A.G.F.) In Brief Landeira et al. show that Jarid2-null ESCs have reduced Wnt9a/Prickle1/Fzd2 and low b-catenin activity, resulting in altered adhesion, constitutive expression of Nanog, and failure to differentiate. Their experiments identify a non-canonical function for Jarid2 in regulating the balance between ESC self-renewal and differentiation. Highlights d ESCs lacking Jarid2 show constitutive Nanog expression d ESCs lacking Jarid2 have reduced PCP/Wnt signaling d Co-culture of Jarid2-null and WT ESCs restores differentiation capability d Jarid2-null ESCs form more than one ICM upon injection to E3.5 mouse blastocysts Landeira et al., 2015, Cell Reports 12, 573–586 July 28, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.celrep.2015.06.060 Cell Reports Article Jarid2 Coordinates Nanog Expression andPCP/WntSignalingRequiredforEfficient ESC Differentiation and Early Embryo Development David Landeira,1,2,5,* Hakan Bagci,1,5 Andrzej R. Malinowski,1,5 Karen E. Brown,1 Jorge Soza-Ried,1 Amelie Feytout,1 Zoe Webster,3 Elodie Ndjetehe,3 Irene Cantone,1 Helena G. Asenjo,2 Neil Brockdorff,4 Thomas Carroll,1 Matthias Merkenschlager,1 and Amanda G. Fisher1,* 1Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK 2Department of Computer Science and A.
    [Show full text]
  • FOI Ref 6871 Response Sent 17 March Can You Please Provide The
    FOI Ref 6871 Response sent 17 March Can you please provide the following details from the most recent records which you hold under The Licensing Act 2003: On-trade alcohol licensed premises, including: Premises Licence Number Date Issued Premises Licence Status (active, expired etc.) Premises Name Premises Address Premises Postcode Premises Telephone Number Premises on-trade Category (e.g. Cafe, Bar, Theatre, Nightclub etc.) Premises Licence Holder Name Premises Licence Holder Address Premises Licence Holder Postcode Designated Premises Supervisor Name Designated Premises Supervisor Address Designated Premises Supervisor Postcode The information you have requested is held and in the attached. However the personal information relating to Designated Premises Supervisors you have requested is refused under the exemption to disclosure at Section 40(2) of the Act Further queries on this matter should be directed to [email protected] Full address Telephone number Licence type Status Date issued Licence holder 1 and 1 Rougamo Ltd, 84 Regent Street, Cambridge, 07730029914 Premises Licence Current Licence 10/03/2020 Yao Qin Cambridgeshire, CB2 1DP 2648 Cambridge, 14A Trinity Street, Cambridge, 01223 506090 Premises Licence Current Registration 03/10/2005 The New Vaults Limited Cambridgeshire, CB2 1TB 2nd View Cafe - Waterstones, 20-22 Sidney Street, Premises Licence Current Registration 17/09/2010 Waterstones Booksellers Ltd Cambridge, Cambridgeshire, CB2 3HG ADC Theatre, Park Street, Cambridge, Cambridgeshire, CB5 01223 359547 Premises Licence
    [Show full text]